Exencial Wealth Advisors, LLC Novartis Ag Transaction History

Exencial Wealth Advisors, LLC

$2.66 Billion
Q4 2024

A detailed history of Exencial Wealth Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Exencial Wealth Advisors, LLC holds 126,147 shares of NVS stock, worth $13.3 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

126,147

Previous 127,144 0.78%

Holding current value

$13.3 Million

Previous $14.6 Million 16.06%

% of portfolio

0.46%

Previous 0.54%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 06, 2025	SELL	$96.78 - $117.18 $96,489 - $116,828	-997 Reduced 0.78%	126,147 $12.3 Million
Q3 2024 Oct 31, 2024	SELL	$106.13 - $120.89 $503,480 - $573,502	-4,744 Reduced 3.6%	127,144 $14.6 Million
Q2 2024 Aug 12, 2024	SELL	$92.57 - $107.37 $852,477 - $988,770	-9,209 Reduced 6.53%	131,888 $14 Million
Q1 2024 May 10, 2024	SELL	$95.27 - $108.47 $280,951 - $319,878	-2,949 Reduced 2.05%	141,097 $13.6 Million
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $547,345 - $602,335	-5,932 Reduced 3.96%	144,046 $14.5 Million
Q3 2023 Nov 08, 2023	SELL	$94.73 - $105.13 $556,444 - $617,533	-5,874 Reduced 3.77%	149,978 $15.3 Million
Q2 2023 Aug 10, 2023	SELL	$92.52 - $104.91 $1.17 Million - $1.33 Million	-12,683 Reduced 7.53%	155,852 $15.7 Million
Q1 2023 May 02, 2023	SELL	$80.03 - $92.81 $561,490 - $651,154	-7,016 Reduced 4.0%	168,535 $15.5 Million
Q4 2022 Feb 14, 2023	SELL	$75.55 - $92.52 $203,002 - $248,601	-2,687 Reduced 1.51%	175,551 $15.9 Million
Q3 2022 Nov 08, 2022	BUY	$74.61 - $87.26 $1.49 Million - $1.74 Million	19,925 Added 12.59%	178,238 $13.5 Million
Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $169,897 - $197,812	-2,110 Reduced 1.32%	158,313 $13.4 Million
Q1 2022 May 12, 2022	SELL	$80.11 - $90.62 $1.61 Million - $1.82 Million	-20,076 Reduced 11.12%	160,423 $14.1 Million
Q4 2021 Feb 10, 2022	SELL	$79.7 - $88.13 $8.39 Million - $9.28 Million	-105,268 Reduced 36.84%	180,499 $15.8 Million
Q3 2021 Nov 04, 2021	BUY	$81.78 - $95.14 $6.51 Million - $7.57 Million	79,616 Added 38.62%	285,767 $23.4 Million
Q2 2021 Aug 16, 2021	SELL	$85.24 - $94.15 $1.33 Million - $1.46 Million	-15,545 Reduced 7.01%	206,151 $18.8 Million
Q1 2021 May 06, 2021	BUY	$83.5 - $98.47 $1.82 Million - $2.15 Million	21,842 Added 10.93%	221,696 $19 Million
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $2.54 Million - $3.07 Million	-32,517 Reduced 13.99%	199,854 $18.9 Million
Q3 2020 Nov 13, 2020	BUY	$82.14 - $91.0 $887,522 - $983,255	10,805 Added 4.88%	232,371 $20.2 Million
Q2 2020 Aug 17, 2020	BUY	$80.93 - $91.1 $328,333 - $369,592	4,057 Added 1.87%	221,566 $19.4 Million
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $623,592 - $873,664	8,824 Added 4.23%	217,509 $17.9 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $1.71 Million - $1.93 Million	20,243 Added 10.74%	208,685 $19.8 Million
Q3 2019 Nov 13, 2019	BUY	$85.54 - $94.26 $2.31 Million - $2.55 Million	27,013 Added 16.73%	188,442 $16.4 Million
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $29,783 - $36,656	-395 Reduced 0.24%	161,429 $14.7 Million
Q1 2019 May 08, 2019	SELL	$75.32 - $86.15 $2.73 Million - $3.12 Million	-36,232 Reduced 18.29%	161,824 $15.6 Million
Q4 2018 Feb 06, 2019	SELL	$73.66 - $82.02 $204,038 - $227,195	-2,770 Reduced 1.38%	198,056 $17 Million
Q3 2018 Nov 05, 2018	SELL	$66.94 - $77.43 $233,085 - $269,611	-3,482 Reduced 1.7%	200,826 $17.3 Million
Q2 2018 Aug 01, 2018	BUY	$64.91 - $73.36 $545,568 - $616,590	8,405 Added 4.29%	204,308 $15.4 Million
Q1 2018 May 09, 2018	SELL	$70.39 - $84.15 $15,415 - $18,428	-219 Reduced 0.11%	195,903 $15.8 Million
Q4 2017 Feb 09, 2018	BUY	$72.33 - $77.64 $1.44 Million - $1.54 Million	19,868 Added 11.27%	196,122 $16.5 Million
Q3 2017 Nov 08, 2017	BUY	$74.14 - $77.27 $13.1 Million - $13.6 Million	176,254	176,254 $15.1 Million

Others Institutions Holding NVS

# of Institutions

1,462

Shares Held

132M

Call Options Held

1.33M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $227B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exencial Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exencial Wealth Advisors, LLC with notifications on news.

Account

Exencial Wealth Advisors, LLC Novartis Ag Transaction History